-
-
Recent Posts
- Coronavirus today and the SCI community tomorrow
- Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: Martin McGlynn
Stem Cells Inc. update at Alliance for Regenerative Medicine (ARM)
Martin McGlynn, President and CEO of Stem Cells Inc. gives an update on Investor Day in New York City. For spinal cord injury they plan to release data in the second quarter of 2014 and open 20-30 additional sites to … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research
Tagged Alliance for Regenerative Medicine, Martin McGlynn, Stem Cells Inc
Comments Off on Stem Cells Inc. update at Alliance for Regenerative Medicine (ARM)
CNS Panel Discussion, StemCells Inc. and Asterias Biotherapeutics at Alliance for Regenerative Medicine Investor Day
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged Alliance for Regenerative Medicine, axon regeneration, chronic spinal cord injury, clinical trials spinal cord injury, Dr. Aileen Anderson, Dr. Stephen Huhn, embryonic stem cells, locomotion, Martin McGlynn, motor function, neurite growth, paralysis, regeneration, spinal cord injury, spinal cord injury research, stem cell therapy, StemCells Inc, U2FP, Unite 2 Fight Paralysis, Unite2FightParalysis
Comments Off on CNS Panel Discussion, StemCells Inc. and Asterias Biotherapeutics at Alliance for Regenerative Medicine Investor Day
SPINAL CORD INJURY RESEARCH AND SCIENCE 